Christopher Paschen
Overview
Explore the profile of Christopher Paschen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paschen C, Koeller M, Schachner H, Nackenhorst M, Klager J, Oszwald A, et al.
Hypertension
. 2025 Mar;
PMID: 40047102
Background: Arterial hypertension (HTN) and type 2 diabetes (T2DM) are contributors to chronic kidney disease leading to glomerulomegaly and podocyte loss. Enlarged glomeruli and podocyte depletion are associated with kidney...
2.
Kurnikowski A, Werzowa J, Hodlmoser S, Krenn S, Paschen C, Mussnig S, et al.
Kidney Med
. 2024 Aug;
6(8):100860.
PMID: 39157193
Rationale & Objectives: Hyperglycemia is frequently observed early after transplantation and associated with development of post-transplant diabetes mellitus (PTDM). Here, we assessed continuous subcutaneous insulin infusion (CSII) targeting afternoon hyperglycemia....
3.
Mussnig S, Schmiedecker M, Waller M, Niknam J, Paschen C, Schneditz D, et al.
Nutrition
. 2023 Jul;
114:112131.
PMID: 37467529
Objectives: The Body Composition Monitor (BCM) (Fresenius Medical Care) measures body impedances in alternating currents to subsequently calculate fat and lean tissue mass, fluid compartments, and overhydration (OH). The aim...
4.
Paschen C, Moll M, Altorjai G, Hecking M, Fuereder T, Widder J, et al.
Head Neck
. 2023 Jun;
45(8):2087-2097.
PMID: 37345576
Objective: Nephrotoxicity is frequent in cisplatin-based chemoradiation of head and neck squamous cell carcinoma (HNSCC). Toxicity outcomes and achieved cisplatin-doses after change of departmental hydration policy are presented. Methods: We...
5.
Schmiedecker M, Krenn S, Waller M, Paschen C, Mussnig S, Niknam J, et al.
Hemodial Int
. 2023 Jan;
27(2):174-183.
PMID: 36703281
Introduction: Prescribing the ultrafiltration in hemodialysis patients remains challenging and might benefit from the information on absolute blood volume, estimated by intradialytic dialysate bolus administration. Here, we aimed at determining...
6.
Moll M, DAndrea D, Zaharie A, Grubmuller B, Paschen C, Zehetmayer S, et al.
Strahlenther Onkol
. 2022 Mar;
198(8):719-726.
PMID: 35284951
Purpose: Hypofractionated radiotherapy for prostate cancer is well established for definitive treatment, but not well defined in the postoperative setting. The purpose of this analysis was to assess oncologic outcomes...
7.
Robak O, Grafeneder-Weissteiner T, Schellongowski P, Bojic A, Paschen C, Hermann A, et al.
ASAIO J
. 2022 Feb;
68(11):1372-1378.
PMID: 35184088
Extracorporeal lung support includes the risk of hemolysis due to suction pressures. Manufacturers measure the negative suction pressure across drainage cannulas for their products in vitro using water. Clinical experience...
8.
Reindl-Schwaighofer R, Heinzel A, Mayrdorfer M, Jabbour R, Hofbauer T, Merrelaar A, et al.
JAMA Intern Med
. 2021 Dec;
182(2):165-171.
PMID: 34928302
Importance: Fewer than 50% of kidney transplant recipients (KTRs) develop antibodies against the SARS-CoV-2 spike protein after 2 doses of an mRNA vaccine. Preliminary data suggest that a heterologous vaccination,...
9.
Moll M, Renner A, Kirisits C, Paschen C, Zaharie A, Goldner G
Strahlenther Onkol
. 2021 Aug;
197(11):986-992.
PMID: 34351453
Purpose: This study's objective was the comparison of external beam radiotherapy (EBRT) and I‑125 seed brachytherapy regarding clinical outcome and development of side effects. Patients And Methods: In all, 462...
10.
Moll M, Paschen C, Zaharie A, Berndl F, Goldner G
Strahlenther Onkol
. 2020 Jul;
197(2):118-123.
PMID: 32642874
Purpose: The goal of our study was comparison of external beam radiotherapy (EBRT) and I‑125 seeds brachytherapy in terms of biochemical control and development of late gastrointestinal and genitourinary side...